Поисковый запрос: (<.>S=ПАНОБИНОСТАТ<.>) |
Общее количество найденных документов : 20
Показаны документы с 1 по 20
|
1.
| Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin lymphoma // Brit. J. Haematol., 2009. Vol. 147, N 1.-С.97-101
|
2.
| Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin lymphoma // Brit. J. Haematol., 2009. Vol. 147, N 1.-С.97-101
|
3.
| Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin lymphoma // Brit. J. Haematol., 2009. Vol. 147, N 1.-С.97-101
|
4.
| Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance // Int. J. Cancer, 2010. Vol. 127, N 9.-С.2199-2208
|
5.
| Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance // Int. J. Cancer, 2010. Vol. 127, N 9.-С.2199-2208
|
6.
| Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance // Int. J. Cancer, 2010. Vol. 127, N 9.-С.2199-2208
|
7.
| The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression // Proc. Nat. Acad. Sci. USA, 2010. Vol. 107, N 24.-С.11032-11037
|
8.
| The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression // Proc. Nat. Acad. Sci. USA, 2010. Vol. 107, N 24.-С.11032-11037
|
9.
| Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo // Int. J. Cancer, 2012. Vol. 130, N 3.-С.694-704
|
10.
| Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo // Int. J. Cancer, 2012. Vol. 130, N 3.-С.694-704
|
11.
| Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo // Int. J. Cancer, 2012. Vol. 130, N 3.-С.694-704
|
12.
| Панобиностат у пациентов с лимфомой Ходжкина, рецидивирующей после аутологичной трансплантации стволовых гемопоэтических клеток или рефрактерной к ней: результаты исследования II фазы // J. Clin. Oncol., 2012. Т. 6, N 3.-С.209
|
13.
| Панобиностат у пациентов с лимфомой Ходжкина, рецидивирующей после аутологичной трансплантации стволовых гемопоэтических клеток или рефрактерной к ней: результаты исследования II фазы // J. Clin. Oncol., 2012. Т. 6, N 3.-С.209
|
14.
| Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis // Brit. J. Haematol., 2013. Vol. 162, N 3.-С.326-327
|
15.
| Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis // Brit. J. Haematol., 2013. Vol. 162, N 3.-С.326-327
|
16.
| The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways // Brit. J. Haematol., 2013. Vol. 163, N 1.-С.72-73
|
17.
| The phosphatidylinositol 3-kinases (PI3K) inhibitor GS-1101 synergistically potentiates histone deacetylase inhibitor-induced proliferation inhibition and apoptosis through the inactivation of PI3K and extracellular signal-regulated kinase pathways // Brit. J. Haematol., 2013. Vol. 163, N 1.-С.72-73
|
18.
| Применение панобиностата и бортезомиба при рецидивирующей или рецидивирующей/рефрактерной множественной миеломе: исследование Ib фазы // J. Clin. Oncol., 2013. Т. 7, N 4.-С.359
|
19.
| Применение панобиностата и бортезомиба при рецидивирующей или рецидивирующей/рефрактерной множественной миеломе: исследование Ib фазы // J. Clin. Oncol., 2013. Т. 7, N 4.-С.359
|
20.
| Innate immune activity correlates with CD4T cell-associated HIV-1 DNA decline during latency-reversing treatment with panobinostat // J. Virol., 2015. Vol. 89, N 20.-С.10176-10189
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"